1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AKOYA BIOSCIENCES INC
Akoya Biosciences Inc XNAS: AKYA

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Akoya Biosciences Inc

The latest disclosure was made by Thomas P. Schnettler in Akoya Biosciences Inc where a trade of 16,860 Stock Option (Right to Buy) done was reported to US exchanges on July 8, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Thomas P. Schnettler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 16,860 0 - - Stock Option (Right to Buy)
Thomas P. Schnettler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 50,000 0 - - Stock Option (right to buy)
Thomas P. Schnettler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 56,322 0 - - Stock Option (right to buy)
Thomas P. Schnettler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 30,549 0 - - Stock Option (right to buy)
Myla P. Lai-Goldman Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 38,993 0 - - Stock Option (Right to Buy)
Myla P. Lai-Goldman Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 20,000 0 - - Common Stock
Myla P. Lai-Goldman Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 50,000 0 - - Stock Option (right to buy)
Myla P. Lai-Goldman Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 56,322 0 - - Stock Option (right to buy)
Myla P. Lai-Goldman Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 30,549 0 - - Stock Option (right to buy)
Scott Mendel Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 30,549 0 - - Stock Option (right to buy)
Scott Mendel Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 35,562 0 - - Stock Option (right to buy)
Scott Mendel Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 28,500 0 - - Common Stock
Scott Mendel Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 50,000 0 - - Stock Option (right to buy)
Scott Mendel Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 44,959 0 - - Stock Option (right to buy)
Scott Mendel Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 56,322 0 - - Stock Option (right to buy)
Thomas A. Raffin Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 50,000 0 - - Stock Option (right to buy)
Thomas A. Raffin Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 234,592 0 - - Common Stock
Thomas A. Raffin Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 1,737,712 0 - - Common Stock
Thomas A. Raffin Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 15,937,535 0 - - Common Stock
Thomas A. Raffin Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 16,860 0 - - Stock Option (Right to Buy)
Thomas A. Raffin Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 30,549 0 - - Stock Option (right to buy)
Thomas A. Raffin Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 56,322 0 - - Stock Option (right to buy)
Robert G. Shepler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 16,860 0 - - Stock Option (Right to Buy)
Robert G. Shepler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 30,549 0 - - Stock Option (right to buy)
Robert G. Shepler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 56,322 0 - - Stock Option (right to buy)
Robert G. Shepler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 50,000 0 - - Stock Option (right to buy)
Matthew Winkler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 16,860 0 - - Stock Option (Right to Buy)
Matthew Winkler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 30,549 0 - - Stock Option (right to buy)
Matthew Winkler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 56,322 0 - - Stock Option (right to buy)
Matthew Winkler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 50,000 0 - - Stock Option (right to buy)
Matthew Winkler Director Other type of transaction at price $ 0.00 per share. 08 Jul 2025 984,513 0 - - Common Stock
John Frederick Ek CFO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 70,000 0 - - Employee Stock Option (Right to Buy)
John Frederick Ek CFO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 160,000 0 - - Employee Stock Option (Right to Buy)
John Frederick Ek CFO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 20,000 0 - - Common Stock
John Frederick Ek CFO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 193,750 0 - - Common Stock
John Frederick Ek CFO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 54,452 193,750 - - Common Stock
Brian McKelligon Director, President and CEO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 175,000 0 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 393,338 813,464 - - Common Stock
Brian McKelligon Director, President and CEO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 331,090 1,144,554 - - Common Stock
Brian McKelligon Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 Jul 2025 196,866 947,688 - - Common Stock
Brian McKelligon Director, President and CEO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 947,688 0 - - Common Stock
Brian McKelligon Director, President and CEO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 393,338 0 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 331,090 0 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 241,592 0 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 160,000 0 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Other type of transaction at price $ 0.00 per share. 08 Jul 2025 160,000 0 - - Employee Stock Option (Right to Buy)
Niro Ramachandran Chief Business Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 45,000 0 - - Employee Stock Option (Right to Buy)
Niro Ramachandran Chief Business Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 70,000 0 - - Employee Stock Option (Right t
Niro Ramachandran Chief Business Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 151,930 130,625 - - Common Stock
Niro Ramachandran Chief Business Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 130,625 0 - - Common Stock
Niro Ramachandran Chief Business Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 62,566 0 - - Employee Stock Option (Right to Buy)
Niro Ramachandran Chief Business Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 45,000 0 - - Employee Stock Option (Right to Buy)
Niro Ramachandran Chief Business Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 62,566 324,703 - - Common Stock
Niro Ramachandran Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 Jul 2025 42,148 282,555 - - Common Stock
Jennifer Kamocsay Chief Legal Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 16,772 162,500 - - Common Stock
Jennifer Kamocsay Chief Legal Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 162,500 0 - - Common Stock
Jennifer Kamocsay Chief Legal Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 75,000 0 - - Employee Stock Option (Right to Buy)
Jennifer Kamocsay Chief Legal Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 70,000 0 - - Employee Stock Option (Right to Buy)
Pascal Bamford Chief Clinical Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 15,000 0 - - Employee Stock Option (Right to Buy)
Pascal Bamford Chief Clinical Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 9,488 196,250 - - Common Stock
Pascal Bamford Chief Clinical Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 196,250 0 - - Common Stock
Pascal Bamford Chief Clinical Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 150,000 0 - - Employee Stock Option (Right to Buy)
Pascal Bamford Chief Clinical Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 25,000 0 - - Employee Stock Option (Right to Buy)
Pascal Bamford Chief Clinical Officer Other type of transaction at price $ 0.00 per share. 08 Jul 2025 50,000 0 - - Employee Stock Option (Right to Buy)
Pascal Bamford Chief Clinical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.25 per share. 01 Jun 2025 670 205,738 - 1.3 838 Common Stock
John Frederick Ek CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. 01 Apr 2025 16,432 248,202 - 1.3 22,183 Common Stock
Brian McKelligon Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.70 per share. 23 Mar 2025 7,550 420,126 - 1.7 12,835 Common Stock
Niro Ramachandran Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.70 per share. 23 Mar 2025 2,310 287,210 - 1.7 3,927 Common Stock
John Frederick Ek CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. 01 Mar 2025 3,594 264,634 - 1.6 5,858 Common Stock
Brian McKelligon Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. 01 Mar 2025 8,257 427,676 - 1.6 13,459 Common Stock
Brian McKelligon Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. 01 Mar 2025 7,550 435,933 - 1.6 12,307 Common Stock
Niro Ramachandran Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. 01 Mar 2025 2,310 293,114 - 1.6 3,765 Common Stock
Niro Ramachandran Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. 01 Mar 2025 3,594 289,520 - 1.6 5,858 Common Stock
Jennifer Kamocsay Chief Legal Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. 01 Mar 2025 3,594 179,272 - 1.6 5,858 Common Stock
Jennifer Kamocsay Chief Legal Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. 01 Mar 2025 3,851 182,866 - 1.6 6,277 Common Stock
Pascal Bamford Chief Clinical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. 01 Mar 2025 1,283 208,975 - 1.6 2,091 Common Stock
Pascal Bamford Chief Clinical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. 01 Mar 2025 2,567 206,408 - 1.6 4,184 Common Stock
John Frederick Ek CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Nov 2024 87,500 268,228 - 0 Common Stock
Brian McKelligon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Nov 2024 218,750 443,483 - 0 Common Stock
Niro Ramachandran Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Nov 2024 87,500 295,424 - 0 Common Stock
Jennifer Kamocsay Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Nov 2024 87,500 186,717 - 0 Common Stock
Pascal Bamford Chief Clinical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Nov 2024 87,500 210,258 - 0 Common Stock
Scott Mendel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2024 44,959 44,959 - - Stock Option (right to buy)
Pascal Bamford Chief Clinical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Aug 2024 40,000 122,758 - 0 Common Stock
Brian McKelligon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 11 Jun 2024 7,500 232,233 - 0.3 2,273 Common Stock
Brian McKelligon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2024 7,500 275,629 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Sale of securities on an exchange or to another person at price $ 2.08 per share. 11 Jun 2024 7,500 224,733 - 2.1 15,630 Common Stock
Brian McKelligon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2024 7,500 283,129 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Sale of securities on an exchange or to another person at price $ 2.01 per share. 06 Jun 2024 7,500 224,733 - 2.0 15,064 Common Stock
Brian McKelligon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 06 Jun 2024 7,500 232,233 - 0.3 2,273 Common Stock
Thomas P. Schnettler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Myla P. Lai-Goldman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Scott Mendel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Thomas A. Raffin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Robert G. Shepler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Matthew Winkler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
John Frederick Ek CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. 01 Apr 2024 14,272 180,728 - 4.6 65,080 Common Stock
Frederic Pla Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.79 per share. 23 Mar 2024 2,006 101,500 - 4.8 9,609 Common Stock
Brian McKelligon Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.79 per share. 23 Mar 2024 7,135 224,733 - 4.8 34,177 Common Stock
Niro Ramachandran Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.79 per share. 23 Mar 2024 2,006 207,924 - 4.8 9,609 Common Stock
Brian McKelligon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 20 Mar 2024 7,500 239,368 - 0.3 2,273 Common Stock
Brian McKelligon Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.97 per share. 20 Mar 2024 7,500 231,868 - 5.0 37,243 Common Stock
Brian McKelligon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Mar 2024 7,500 290,629 - - Employee Stock Option (Right to Buy)
Robert G. Shepler Director Gift of securities by or to the insider at price $ 0.00 per share. 13 Mar 2024 369,592 369,592 - 0 Common Stock
Robert G. Shepler Director Gift of securities by or to the insider at price $ 0.00 per share. 13 Mar 2024 369,592 0 - 0 Common Stock
Brian McKelligon Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.94 per share. 13 Mar 2024 7,500 224,368 - 4.9 37,035 Common Stock
Brian McKelligon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 13 Mar 2024 7,500 239,368 - 0.3 2,273 Common Stock
Brian McKelligon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 7,500 298,129 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.94 per share. 13 Mar 2024 7,500 231,868 - 4.9 37,043 Common Stock
Frederic Pla Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 70,000 70,000 - - Employee Stock Option (Right to Buy)
Frederic Pla Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 35,000 105,555 - 0 Common Stock
Frederic Pla Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. 22 Feb 2024 2,049 103,506 - 6.0 12,355 Common Stock
John Frederick Ek CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 35,000 195,000 - 0 Common Stock
John Frederick Ek CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 70,000 70,000 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 175,000 175,000 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 87,500 240,063 - 0 Common Stock
Brian McKelligon Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. 22 Feb 2024 8,195 231,868 - 6.0 49,416 Common Stock
Niro Ramachandran Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 35,000 212,235 - 0 Common Stock
Niro Ramachandran Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. 22 Feb 2024 2,305 209,930 - 6.0 13,899 Common Stock
Niro Ramachandran Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 70,000 70,000 - - Employee Stock Option (Right to Buy)
Jennifer Kamocsay General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 35,000 102,500 - 0 Common Stock
Jennifer Kamocsay General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 70,000 70,000 - - Employee Stock Option (Right to Buy)
Jennifer Kamocsay General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. 22 Feb 2024 3,283 99,217 - 6.0 19,796 Common Stock
McKelligon Brian Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.48 per share. 19 Dec 2023 7,500 152,563 - 4.5 33,566 Common Stock
Brian McKelligon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 19 Dec 2023 7,500 160,063 - 0.3 2,273 Common Stock
McKelligon Brian Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 7,500 305,629 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 12 Dec 2023 7,500 160,063 - 0.3 2,273 Common Stock
McKelligon Brian Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Dec 2023 7,500 313,129 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.25 per share. 12 Dec 2023 7,500 152,563 - 4.2 31,871 Common Stock
Myla P. Lai-Goldman Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 12 Jun 2023 20,000 20,000 - 5 100,000 Common Stock
Scott Mendel Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 12 Jun 2023 20,000 28,500 - 5 100,000 Common Stock
Thomas A. Raffin Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 12 Jun 2023 20,000 234,592 - 5 100,000 Common Stock
Thomas A. Raffin Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 12 Jun 2023 1,803,373 15,937,535 - 5 9,016,865 Common Stock
Thomas A. Raffin Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 12 Jun 2023 196,627 1,737,712 - 5 983,135 Common Stock
Robert G. Shepler Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 12 Jun 2023 120,000 369,592 - 5 600,000 Common Stock
Matthew Winkler Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 12 Jun 2023 203,388 984,513 - 5 1,016,940 Common Stock
John Frederick Ek CFO Purchase of securities on an exchange or from another person at price $ 5.00 per share. 12 Jun 2023 20,000 20,000 - 5 100,000 Common Stock
Brian McKelligon Director, President/CEO Sale of securities on an exchange or to another person at price $ 5.71 per share. 06 Jun 2023 5,000 152,563 - 5.7 28,537 Common Stock
Brian McKelligon Director, President/CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2023 5,000 328,129 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President/CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 06 Jun 2023 5,000 157,563 - 0.3 1,515 Common Stock
Thomas P. Schnettler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 56,322 56,322 - - Stock Option (Right to Buy)
Myla P. Lai-Goldman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 56,322 56,322 - - Stock Option (Right to Buy)
Scott Mendel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 56,322 56,322 - - Stock Option (Right to Buy)
Thomas A. Raffin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 56,322 56,322 - - Stock Option (Right to Buy)
Robert G. Shepler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 56,322 56,322 - - Stock Option (Right to Buy)
Matthew Winkler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 56,322 56,322 - - Stock Option (Right to Buy)
Garry Nolan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 56,322 56,322 - - Stock Option (Right to Buy)
Frederic Pla Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.69 per share. 23 Mar 2023 1,945 40,555 - 7.7 14,957 Common Stock
Brian McKelligon Director, President/CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.69 per share. 23 Mar 2023 7,437 152,563 - 7.7 57,191 Common Stock
Niro Ramachandran Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.69 per share. 23 Mar 2023 1,945 177,235 - 7.7 14,957 Common Stock
John Frederick Ek CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 160,000 160,000 - 0 Common Stock
John Frederick Ek CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 160,000 160,000 - - Employee Stock Option (Right to Buy)
Jennifer Kamocsay General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 75,000 75,000 - - Employee Stock Option (Right to Buy)
Jennifer Kamocsay General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 37,500 37,500 - 0 Common Stock
Brian McKelligon Director, President/CEO Sale of securities on an exchange or to another person at price $ 9.13 per share. 14 Mar 2023 4,774 160,226 - 9.1 43,610 Common Stock
Brian McKelligon Director, President/CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2023 5,000 333,129 - - Employee Stock Option (Right to Buy)
Brian McKelligon Director, President/CEO Sale of securities on an exchange or to another person at price $ 9.92 per share. 14 Mar 2023 226 160,000 - 9.9 2,241 Common Stock
Brian McKelligon Director, President/CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 14 Mar 2023 5,000 165,000 - 0.3 1,515 Common Stock
Frederic Pla Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 40,000 40,000 - - Employee Stock Option (Right to Buy)
Frederic Pla Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 20,000 42,500 - 0 Common Stock
Brian McKelligon President/CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 160,000 160,000 - - Employee Stock Option (Right to Buy)
Brian McKelligon President/CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 80,000 160,000 - 0 Common Stock
Niro Ramachandran Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 45,000 45,000 - - Employee Stock Option (Right to Buy)
Niro Ramachandran Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 22,500 179,180 - 0 Common Stock
Marilee Moy CHIEF PEOPLE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 20,000 20,000 - 0 Common Stock
Marilee Moy CHIEF PEOPLE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 40,000 40,000 - - Employee Stock Option (Right to Buy)
Ehab El-Gabry Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 32,500 32,500 - - Employee Stock Option (Right to Buy)
Ehab El-Gabry Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 16,250 16,250 - 0 Common Stock
Niro Ramachandran Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2023 34,000 62,566 - - Employee Stock Option (Right to Buy)
Niro Ramachandran Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.91 per share. 15 Feb 2023 34,000 156,680 - 0.9 30,940 Common Stock
Joseph Driscoll Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Dec 2022 250,000 110,958 - - Employee Stock Option (Right to Buy)
Joseph Driscoll Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.44 per share. 22 Dec 2022 250,000 262,500 - 0.4 110,000 Common Stock
Joseph Driscoll Chief Financial Officer Sale of securities on an exchange or to another person at price $ 12.67 per share. 14 Dec 2022 10,039 12,500 - 12.7 127,187 Common Stock
Joseph Driscoll Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.44 per share. 14 Dec 2022 14,574 27,074 - 0.4 6,413 Common Stock
Joseph Driscoll Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.44 per share. 14 Dec 2022 10,039 22,539 - 0.4 4,417 Common Stock
Joseph Driscoll Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2022 14,574 108,712 - - Employee Stock Option (Right to Buy
Joseph Driscoll Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2022 10,039 123,466 - - Employee Stock Option (Right to Buy)
Joseph Driscoll Chief Financial Officer Sale of securities on an exchange or to another person at price $ 12.45 per share. 14 Dec 2022 14,574 12,500 - 12.5 181,519 Common Stock
Thomas P. Schnettler Director Sale of securities on an exchange or to another person at price $ 13.03 per share. 13 Dec 2022 71,050 2,742,721 - 13.0 925,782 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.25 per share. 13 Dec 2022 100 555,084 - 13.3 1,325 Common Stock
Brian McKelligon President/CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 06 Dec 2022 5,000 85,000 - 0.3 1,515 Common Stock
Brian McKelligon President/CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Dec 2022 5,000 338,129 - - Employee Stock Option (Right to Buy)
Brian McKelligon President/CEO Sale of securities on an exchange or to another person at price $ 12.08 per share. 06 Dec 2022 5,000 80,000 - 12.1 60,415 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.25 per share. 02 Dec 2022 1,100 591,978 - 13.3 14,575 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.36 per share. 01 Dec 2022 5,000 593,078 - 13.4 66,788 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.25 per share. 16 Nov 2022 300 598,078 - 13.3 3,976 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.31 per share. 10 Nov 2022 3,810 618,978 - 13.3 50,705 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.28 per share. 10 Nov 2022 600 598,378 - 13.3 7,966 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.29 per share. 10 Nov 2022 20,000 598,978 - 13.3 265,858 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.26 per share. 14 Sep 2022 8,305 622,788 - 13.3 110,084 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.30 per share. 09 Sep 2022 1,800 631,093 - 13.3 23,944 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.31 per share. 09 Sep 2022 22,191 632,893 - 13.3 295,338 Common Stock
Brian McKelligon President/CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 07 Sep 2022 5,000 85,000 - 0.3 1,515 Common Stock
Brian McKelligon President/CEO Sale of securities on an exchange or to another person at price $ 12.83 per share. 07 Sep 2022 5,000 80,000 - 12.8 64,170 Common Stock
Brian McKelligon President/CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Sep 2022 5,000 343,129 - - Employee Stock Option (Right to Buy)
Brian McKelligon President/CEO Sale of securities on an exchange or to another person at price $ 10.25 per share. 15 Jun 2022 5,000 80,000 - 10.3 51,260 Common Stock
Brian McKelligon President/CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2022 5,000 348,129 - - Employee Stock Option (Right to Buy)
Brian McKelligon President/CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 15 Jun 2022 5,000 85,000 - 0.3 1,515 Common Stock
Thomas P. Schnettler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 30,549 30,549 - - Stock Option (Right to Buy
Myla P. Lai-Goldman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 30,549 30,549 - - Stock Option (Right to Buy
Scott Mendel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 30,549 30,549 - - Stock Option (Right to Buy
Thomas A. Raffin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 30,549 30,549 - - Stock Option (Right to Buy
Robert G. Shepler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 30,549 30,549 - - Stock Option (Right to Buy
Matthew Winkler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 30,549 30,549 - - Stock Option (Right to Buy
Garry Nolan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 30,549 30,549 - - Stock Option (Right to Buy
Ehab El-Gabry Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 150,000 150,000 - - Employee Stock Option (Right to Buy)
Niro Ramachandran Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.91 per share. 13 Apr 2022 75,107 122,680 - 0.9 68,347 Common Stock
Niro Ramachandran Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Apr 2022 75,107 96,566 - - Employee Stock Option (Right to Buy)
Marilee Moy Chief People Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2022 120,000 120,000 - - Employee Stock Option (Right to Buy)
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 13.25 per share. 13 Dec 2021 100 555,084 - 13.3 1,325 Common Stock
Garry Nolan Director Sale of securities on an exchange or to another person at price $ 12.67 per share. 09 Dec 2021 25,000 655,084 - 12.7 316,763 Common Stock
Scott Mendel Director Purchase of securities on an exchange or from another person at price $ 13.16 per share. 19 Nov 2021 8,500 8,500 - 13.2 111,860 Common Stock
Niro Ramachandran Chief Business Officer Purchase of securities on an exchange or from another person at price $ 13.13 per share. 19 Nov 2021 25,000 25,073 - 13.1 328,293 Common Stock
Niro Ramachandran Chief Business Officer Purchase of securities on an exchange or from another person at price $ 12.85 per share. 19 Nov 2021 73 73 - 12.8 938 Common Stock
Robert G. Shepler Director Purchase of securities on an exchange or from another person at price $ 12.92 per share. 18 Nov 2021 20,000 35,000 - 12.9 258,500 Common Stock
Robert G. Shepler Director Purchase of securities on an exchange or from another person at price $ 12.17 per share. 18 Nov 2021 15,000 15,000 - 12.2 182,505 Common Stock
Myla P. Lai-Goldman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2021 38,993 38,993 - - Stock Option (Right to Buy
Scott Mendel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2021 35,562 35,562 - - Stock Option (Right to Buy
Thomas P. Schnettler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2021 16,860 16,860 - - Stock Option (Right to Buy
Robert G. Shepler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2021 16,860 16,860 - - Stock Option (Right to Buy
Matthew Winkler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2021 16,860 16,860 - - Stock Option (Right to Buy
Garry Nolan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2021 16,860 16,860 - - Stock Option (Right to Buy
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters